Abiopharma

Nexalin Technology Receives Nasdaq Listing Status Notification

Corvus Pharmaceuticals Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares, Generating Gross Proceeds of Approximately $201M

CNEY Receives Nasdaq Delisting Determination for Minimum Bid Price Deficiency

UTHR: Notification

UTHR: Notification

Nuwellis Announces Changes to Board of Directors

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Roivant to Report Financial Results for the Third Quarter Ended December 31, 2025, and Provide Business Update on Friday, February 6, 2026

XTL Announces Receipt of Nasdaq Notification Regarding Minimum Stockholders’ Equity Deficiency

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)